Arthneeti
Sale is live|00:00:00

Coromandel International Ltd Q4 FY25 Earnings Analysis

Published 18 Jul 2026 | Fertilizers & Agrochemicals | Market Cap: ₹58.5K Cr

Price

2,034

Market Cap

₹58.5K Cr

P/E Ratio

27.6

Earnings Summary

- The specialty nutrient business aims to double its size from Rs. - Specialty Nutrients segment aims to double its size from Rs.

📊 Revenue & Sales Performance

- The specialty nutrient business aims to double its size from Rs. 550-600 crores to about Rs. 1100-1200 crores in two years. - SSP volumes are targeted to reach 1 million tons in 2 years, with 8 lakh tons expected next year. - The company expects continued volume growth through combination of manufacturing expansions (debottlenecking, new plants) and imports. - Crop protection exports and formulations are expected to grow steadily, with a focus on expanding in Latin America, Southeast Asia, Europe, and U.S. - The retail network is set to double the number of stores from 810 to 1,500+ by FY '27. - Nutrient business volume growth is expected but contingent on capacity and imports. - Water-soluble fertilizers, high-end specialty nutrients, organics, and bio-products are identified as the next growth pillars. - The company is scaling capacities and considering backward integration to reduce import dependence and become a global supplier.

📈 Profitability & Margins

- Specialty Nutrients segment aims to double its size from Rs. 550-600 crores within 2 years, with EBITDA margins expected to expand to 20-25%. - SSP business targeting 1 million ton capacity in 2 years, focusing on value-added products with blended margins around Rs. 2,500 per ton. - Expansion of granulation and phosphoric acid capacity at Kakinada and Vizag plants will drive volume and margin improvements over next 2 years. - Retail business growing strongly with 20% top-line growth Q3 and 17% profitability growth; aiming to double store count from 810 to ~1,500 by FY 2027. - Crop Protection export and domestic formulation businesses targeted for high growth, with new product registrations and geographic expansion underway. - Overall EBITDA margin improvement of around 40% expected in next 2 years with commissioning of sulfuric acid and phosphoric acid plants. - Positive outlook for drone subsidiary and ag-tech investments to contribute to future earnings.

🏗️ Capital Expenditure Plans

- Setting up new granulation trains to increase capacity, supported by captive phosphoric acid and sulfuric acid plants at Kakinada. - Commissioning of a new 2 lakh tons phosphoric acid and related sulfuric acid plant at Kakinada expected by Q4 FY26. - Additional 7.5 lakh tons NPK capacity project at Kakinada initiated (Bhumi Pooja done), expected commercial production by Q4 FY27. - Multi-product plant at Ankleshwar approved, targeting commissioning in 18 months. - Capital investments are being supported with incentives approved by the Andhra Pradesh State Industrial Promotion Board. - Company intends to utilize investable surplus for strategic capital investments. - Investments in subsidiaries and ventures like Baobab Mining (rock phosphate supply), agri drones, and ag-tech startups through Dare Ventures. - Expanding retail footprint with plans to double stores from 810 to around 1,500 by FY27. - Overall focus on backward integration and enhancing specialty nutrient and crop protection capacity.

💰 Fundraising & Capital Structure

- The document does not explicitly mention any current or planned fundraising through debt or equity. - The company is focusing on utilizing investable surplus for capital investments. - It has applied for and received incentives on large capital investments from the Andhra Pradesh government. - The company continues to deploy surplus funds in Board-approved securities and plans to use them for future strategic investments. - There is discussion on capacity expansions and new projects, but no direct mention of raising funds through new debt or equity issuance.

📋 Order Book & Pipeline

- The drone subsidiary has an order book of approximately Rs. 250 crores from the emergency procurement team on defence. - Shipments are pending product delivery inspection (PDI) before dispatch can occur. - The company is currently focusing on the agri drones business and pilot training, expecting positive traction in the coming year. - No specific pending order details were mentioned for other segments in the provided transcript.

Key Metrics

Frequently Asked Questions

What were Coromandel International Ltd Q4 FY25 results?

- The specialty nutrient business aims to double its size from Rs. - Specialty Nutrients segment aims to double its size from Rs.

What is Coromandel International Ltd share price analysis?

Coromandel International Ltd currently shows a neutral. The stock trades at a P/E of 27.6 with a market cap of ₹58,463. Investors should review the full earnings analysis for detailed insights.

Is Coromandel International Ltd planning capital expenditure?

- Setting up new granulation trains to increase capacity, supported by captive phosphoric acid and sulfuric acid plants at Kakinada.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.